Zenith Healthcare Limited (BOM:530665)
3.080
-0.010 (-0.32%)
At close: Aug 17, 2026
Zenith Healthcare Revenue
Zenith Healthcare had revenue of 35.01M INR in the quarter ending June 30, 2026, with 11.11% growth. This brings the company's revenue in the last twelve months to 107.48M, down -9.75% year-over-year. In the fiscal year ending March 31, 2026, Zenith Healthcare had annual revenue of 105.64M, down -7.25%.
Revenue (ttm)
107.48M
Revenue Growth
-9.75%
P/S Ratio
1.54
Revenue / Employee
2.56M
Employees
45
Market Cap
165.52M
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Mar 31, 2026 | 105.64M | -8.25M | -7.25% |
| Mar 31, 2025 | 113.89M | -31.71M | -21.78% |
| Mar 31, 2024 | 145.61M | 13.36M | 10.10% |
| Mar 31, 2023 | 132.25M | -93.34M | -41.38% |
| Mar 31, 2022 | 225.58M | 87.00M | 62.78% |
| Mar 31, 2021 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Related Stocks
| Company Name | Revenue |
|---|---|
| Add-Shop E-Retail | 1.71B |
| Beryl Drugs | 215.51M |
| Unjha Formulations | 152.79M |
| Hamps Bio | 84.75M |
| Norris Medicines | 81.32M |
| Desh Rakshak Aushdhalaya | 66.33M |
| Colinz Laboratories | 58.11M |
| Emmessar Biotech & Nutrition | 23.78M |